Maravai LifeSciences Holdings, Inc. Shares Acquired by Glenmede Trust Co. NA - MarketBeat

MRVI Stock  USD 5.67  0.25  4.22%   
Under 54% of Maravai Lifesciences' investor base is interested to short. The analysis of overall sentiment of trading Maravai Lifesciences Holdings stock suggests that many investors are impartial at this time. Maravai Lifesciences' investing sentiment shows overall attitude of investors towards Maravai Lifesciences Holdings.
  
Maravai LifeSciences Holdings, Inc. Shares Acquired by Glenmede Trust Co. NA MarketBeat

Read at news.google.com
Google News at Macroaxis
  

Maravai Lifesciences Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Maravai Lifesciences can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Maravai Lifesciences Fundamental Analysis

We analyze Maravai Lifesciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Maravai Lifesciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Maravai Lifesciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Valuation

Current Valuation Comparative Analysis

Maravai Lifesciences is currently under evaluation in current valuation category among its peers. Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Maravai Lifesciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Maravai Lifesciences stock to make a market-neutral strategy. Peer analysis of Maravai Lifesciences could also be used in its relative valuation, which is a method of valuing Maravai Lifesciences by comparing valuation metrics with similar companies.

Peers

Maravai Lifesciences Related Equities

ARQTArcutis Biotherapeutics   11.36   
0%
100.0%
EWTXEdgewise Therapeutics   2.48   
0%
21.0%
ALECAlector   1.57   
0%
13.0%
AGIOAgios Pharm   1.24   
0%
10.0%
ARGXArgenx NV   0.32   
0%
2.0%
KRYSKrystal Biotech   0.26   
0%
2.0%
FOLDAmicus Therapeutics   0.20   
0%
1.0%
ROIVRoivant Sciences   0.16   
0%
1.0%
ASNDAscendis Pharma   0.18   
1.0%
0%
AKROAkero Therapeutics   0.22   
1.0%
0%
ABUSArbutus Biopharma   0.29   
2.0%
0%
HALOHalozyme Therapeutics   0.56   
4.0%
0%
APLSApellis Pharmaceuticals   0.62   
5.0%
0%
DNLIDenali Therapeutics   0.64   
5.0%
0%
CYTKCytokinetics   0.69   
6.0%
0%
INSMInsmed   0.95   
8.0%
0%
RAREUltragenyx   1.04   
9.0%
0%
INCYIncyte   1.14   
10.0%
0%
IMVTImmunovant   1.84   
16.0%
0%
LEGNLegend Biotech   2.46   
21.0%
0%
PTGXProtagonist Therapeutics   2.56   
22.0%
0%
HRMYHarmony Biosciences   3.02   
26.0%
0%

Complementary Tools for Maravai Stock analysis

When running Maravai Lifesciences' price analysis, check to measure Maravai Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Maravai Lifesciences is operating at the current time. Most of Maravai Lifesciences' value examination focuses on studying past and present price action to predict the probability of Maravai Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Maravai Lifesciences' price. Additionally, you may evaluate how the addition of Maravai Lifesciences to your portfolios can decrease your overall portfolio volatility.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Fundamental Analysis
View fundamental data based on most recent published financial statements
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals